Is it possible to model psychotic states in animals?

Angnst B.M. , Gershon S. 1970 The phenomenology of experimentally induced amphetamine psychosis—preliminary observations. Biological Psychiatry 2 95-107

Angrist B.M. , Sudilovsky A. 1978 Central nervous system stimulants: historical aspects and clinical effects In. Handbook of psychopharmacology, vol. 2 (eds S D Iversen, L L Iversen, S H Snyder), pp. 99-165, Plenum Press, New York

Angrist B.M. , Rotrosen J. , Gershon S. 1980 Differential effects of amphetamine and neuroleptics on negative vs positive symptoms in schizophrenia Psychopharmacology 72 17-19

Antelman S.M. , Caggiula A.R. 1977a Norepinephrine-dopamine interactions and behaviour Science 195: 646-653

Antelman S.M. , Caggmla A.R. 1977b Tails of stress-induced behaviour: a neuropharmacological model In. Animal models in psychiatry and neurology (eds I Hanin, E Usdin), pp 227-245. Pergamon, Oxford

Antelman S.M. , Eichler H.T. , Black C.A. , Kocen D. 1980 Interchangeability of stress and amphetamine in sensitization Science, 207: 329-331

Asarnow R. , MacCrimmon D. 1981 Span of apprehension deficits during the post-psychotic stages of schizophrenia. Archives of General Psychiatry 38: 1006-1011

Bacopolous N. 1981 Biochemical mechanism of tolerance to neuroleptic drugs, regional differences in rat brain. European Journal of Pharmacology 70: 585-588

Bacopoulos N. , Redmond D. , Baulu J. , Roth R. 1980 Chronic haloperidol or fluphenazine effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cereopithecus aethiops (vervet monkey) Journal of Pharmacology and Experimental Therapy 212: 1-5

Bannon M.J. , Roth R.H. 1983 Pharmacology of mesocortical dopamine neurons Pharmacology Reviews 35: 53-68

Bannon M.J. , Wolf M.E. , Roth R.H. 1983 Pharmacology of dopamine neurones innervating the prefrontal, cingulate and piriform cortices. European Journal of Pharmacology 91: 119-125

Barnes T R E , Braude W.M. 1985 Akathisia variants and tardive dyskinesia Archives of General Psychiatry 42: 874-878

Bell D.S. 1965 Comparison of amphetamine psychosis and schizophrenia British Journal of Psychiatry 111: 701-707

Benes F.M. , Davidson J. , Bird E.D. 1986 Quantitative cytoarchitectural studies of the cerebral cortex in schizophrenics Archives of General Psychiatry 43: 31-35

Berman K.F. , Zec R.F. , Wemberger D.R. 1986 Role of neuroleptic treatment, attention and mental effort Archives of General Psychiatry 43: 126-135

Bleuler E. 1911 Dementia praecox translated in 1950 by H Zinkin. International University Press, New York

Bogerts B. , Meertz E. , Schonfelds-Bausch R. 1985 Basal ganglia and limbic system pathology in schizophrenia Archives of General Psychiatry 42: 784—791

Bracha H.S. , Cabrera F.J. , Karson C.N. , Bigelow L.B. 1985 Lateralisation of visual hallucinations in chronic schizophrenia Biological Psychiatry 20: 1132-1136

Bradbury A.J. , Costall B. , Domeney A.M. , Naylor R.J. 1985 Laterality of dopamine function and neuroleptic action in the amygdala in the rat Neuropharmacology 24: 1163-1170

Braff D. , Saccuzzo D. 1982 Effect of antipsychotic medication on speed of information processing in schizophrenic patients. American Journal of Psychiatry 193: 1127-1130

Braff D.L. , Stone C. , Callaway E. , Geyer M. , Glick I. , Bali L. 1978 Prestimulus effects on human startle reflex in normals and schizophrenics Psychopharmacology 15. 339-343

Brown R. , Colter N. , Corsellis J.A. N., Crow T.J., Frith C.O., Jagoe R., Johnstone E V , Marsh L. 1986 Postmortem evidence of structural brain changes in schizophrenia . Archives of General Psychiatry 43: 36-42

Buchsbaum M.S. , Ingvar D.H. , Kessler R. , Waters et al 1982 Cerebral glucography with positron tomography Archives of General Psychiatry 39: 251-259

Bunney B.S. , Walters J.R. , Kuhar M.J. , Roth R.H. , Aghajanian G.K. 1975 D- and L-amphetamine stereo-isomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons . Psychopharmacology Communications 1: 177-190

Chester G.B. , Jackson D.M. 1981 Swim-induced grooming in mice is mediated by a dopaminergic substrate. Journal of Neural Transmission 50: 47-56

Connell P.H. 1958 Amphetamine psychosis, Maudsley Monograph no. 5. Oxford University Press, Oxford

Connolly J.F. , Gruzelier J.H. , Kleinman K.M. , Hirsch S.R. 1979 Lateralized abnormalities in hemisphere-specific tachistoscopic tasks in psychiatric patients and controls. In: Hemisphere asymmetries of function in psychopathology, pp 527-538. Elsevier-North Holland Biomedical Press, New York

Cook L. , Weidley E. 1957 Behavioural effects of some psychopharmacological agents . Annals of the New York Academy of Science 66: 740-752

Costall B. , Naylor R.H. 1973 Neuroleptic and non-neuroleptic catalepsy. Arzneimittel-Forschung 23: 674-683

Costall B. , Naylor R.J. 1976 Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine European Journal of Pharmacology 35: 161-168

Costall B. , Eniojukan J.F. , Naylor R.J. 1982 Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement. European Journal of Pharmacology 85 125-132

Courvoisier S. , Fournel J. , Kolshy M. , Koetsched P. 1952 Propriétés pharmacodynomiques du chlorhydrate de chloro-3(dimethylamine-3'propyl)-10 phenothiazine (4560 RP) Archives of International Pharmacodynamics 92: 305-361

Crawley J.N. , Stivers J.A. , Blumstein L.K. , Pau S.M. 1985 Cholecystokinin potentiates dopamine-mediated behaviours: evidence for modulation specific to a site of coexistence Journal of Neuroscience 5. 1972-1983

Creese I N R , Iversen S.D. 1975 The pharmacological and anatomical substrates of the amphetamine response in the rat Brain Research 83: 419-436

Creese I N R , Burt D.R. , Synder J.H. 1976 Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192: 481-483

Crow T.J. 1980 Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280: 66-68

Crow T.J. 1981 Biological basis of mental disorders: the case for viral aetiology In: Epidemiological impact of psychotropic drugs (eds G Tognoni, C Bellantuono, M Lader), pp 33-51. Elsevier/North-Holland Biomedical Press, New York

Cunna J.M. , Masur J. 1978 Evaluation of psychotropic drugs, with a modified open field test. Pharmacology 16: 259-267

Cuomo V. , Cagiano R. , Colonna M. , Renna G. , Racagni G. 1986 Influence of SCH-23390, a DAI-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats. Neuropharmacology 25: 1297-1300

Denenberg V.H. 1981 Hemispheric laterality in animals and the effects of early experience Behaviour and Brain Science 4: 1-50

Efron D.H. 1968 Psychopharmacology—a review of progress US Department of Health, Education and Welfare, Washington DC

Eison M.S. , Eison A.S. , Ellison G. 1981 The distribution of d-amphetamme and local glucose utilization in rat brain during continuous amphetamine administration Experimental Brain Research 43: 281-288

Ellinwood E.H. , Escalante D.O. 1972 Chronic methamphetamine intoxication in three species of experimental animals In: Current concepts of amphetamine-abuse (eds E H Ellinwood, S Cohen), p. 959. US Government Printing Office, Washington DC

Ellinwood E.H. , Kilbey M.M. 1975 Amphetamine stereotypy: the influence of environmental factors and prepotent behavioural patterns on its topography and development . Biological Psychiatry 10 3-16

Ellinwood E.H. , Kilbey M.M. 1977 Chronic stimulant intoxication models of psychosis. In: Animal models in psychiatry and neurology (eds I Hanin, E Usdin), pp. 61-74. Pergamon Press, Oxford

Elliott P N C , Jenner P. , Huizing G. , Marsden C.D. , Miller R. 1977 Substituted benzamides as cerebral dopamine antagonists in rodents Neuropharmacology 16 333-342

Ellison G. , Eison M.S. , Huberman H.S. 1978 Stages of constant amphetamine intoxication: delayed appearance of paranoid-like behaviours in rat colonies Psychopharmacology 56: 293-299

Ellison G. , Nielsen E.B. , Lyon M. 1981 Animal model of psychosis hallucinatory behaviours in monkeys during the late stage of continuous amphetamine intoxication Journal of Psychiatric Research 16 13-22

Evenden J.L. , Robbms T.W. 1983 Increased response switching, perseveration and perseverative switching following d-amphetamine in the rat Psychopharmacology , 80: 67-73

Feinberg T.E. , Rifkin A. , Schaffer C. , Walker E. 1986 Facial discrimination and emotional recognition in schizophrenia and affective disorders Archives of General Psychiatry 43: 276-279

Fielding S. , Lal H. 1978 Behavioural actions of neuroleptics In Handbook of psychopharmacology, vol 10 (eds L L Iversen, S D Iversen, S H Synder), pp 91-128 Plenum Press , New York

Fischman M.W. , Schuster C.R. 1977 Long-term behavioural changes in the rhesus monkey after multiple daily injections of d-methylamphetamine Journal of Pharmacology and Experimental Therapy 201 593-605

Flor-Henry P. 1969 Psychosis and temporal lobe epilepsy. Epilepsia 10: 363-395

Franzen G. , Ingvar D.H. 1975 Absence of activation in frontal structures during psychological testing of chronic schizophrenics Journal of Neurology, Neurosurgery and Psychiatry 38: 1027-1032

Frith C.D. 1981 Schizophrenia: an abnormality of consciousness? In Aspects of consciousness, Vol. 2 (eds G Underwood, R Stevens), pp 149-168 Academic Press, London

Frith C.D. , Done D.J. (1983) Stereotyped responding by schizophrenic patients on a two-choice guessing task Psychological Medicine 13 779-786

Gerhardt S. , Geber R. , Liebman J.M. 1985 SCH-23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models Life Sciences 37: 2355-2363

Gerson S.C. , Baldessarini R.J. 1980 Motor effects of serotonin in the central nervous system Life Sciences 27: 1435-1451

Glick S.D. 1983 In: Hemisyndrome, psychobiology, neurology, Psychiatry (ed M S Myslobodsy), pp. 7-26. Academic Press, New York

Goddard G.V. , McIntyre D.C. , Leech C.K. 1969 A permanent change in brain function resulting from daily electrical stimulation Experimental Neurology 25: 296-330

Gould W.M. , Gragg T.M. 1976 Delusions of parasitosis: an approach to the problem Archives of Dermatology 112: 1745-1748

Griffiths J.D. , Cavanaugh J. , Held J. , Oates J. 1972 Dextroamphetamine. evaluation of psychomimetic properties in man Archives of General Psychiatry 26: 97-100

Guenther W. , Breitling D. 1985 Predominant sensorimotor area left hemisphere dysfunction in schizophrenia measured by brain electrical activity mapping. Biological Psychiatry 20: 515-532

Guenther W. , Breitling D. , Banquet J.P. , Marcie P. , Rondot P. 1986 EEG mapping of left hemisphere dysfunction during motor performance in schizophrenia Biological Psychiatry 21: 249-262

Gunne L.M. , Barany S. 1976 Haloperidol-induced tardive dyskinesia in monkeys Psychopharmacology 50 237-240

Heise G.A. , Boff E. 1962 Continuous avoidance as a base-line for measuring behavioural effects of drugs Psychopharmacologia 3. 264-282

Hillsberg B. 1979 A comparison of visual discrimination performance of the dominant and non-dominant hemispheres in schizophrenia In Hemisphere asymmetries of function in psychopathology, (eds J Gruzelier, P Flor-Henry), pp. 527-538. Elsevier-North Holland Biomedical Press , New York

Hornykiewicz O. 1982 Brain catecholamines in schizophrenia—a good case for noradrenaline Nature London 299. 484-486

Hyttel J. 1983 SCH—23390—the first selective D-1 antagonist . European Journal of Pharmacology 91: 153-154

Iorio L.C. , Barnett A. , Leitz F. , Houser V.P. , Korduba K. 1983 SCH-23390, a potential benzodiazepine antipsychotic with unique interactions on dopaminergic systems Journal of Pharmacology and Experimental Therapy 226: 462-468

Iversen L.L. 1978 Biochemical and pharmacological studies: the dopamine hypothesis. In: Schizophrenia (ed J K Wing), pp 89-116 Academic Press, London

Iversen S.D. 1982 In: Substance P in the nervous system Ciba Foundation Volume 91, pp 307-324 Pitman, London

Iversen S.D. 1984 Recent advance in the anatomy and chemistry of the limbic system In Psychopharmacology of the limbic system British Association of Psychopharmacology Monograph 5, (eds M R Trimble, E Zarifian), pp 1-16. Oxford University Press, Oxford

Iversen S.D. 1986 Animal models of schizophrenia. In. Psychopharmacology and treatment of schizophrenia (eds P B Bradley, S Hirsch) Oxford University Press, Oxford, New York

Iversen S.D. , Iversen L.L. 1981 Behavioural pharmacology, 2nd edn Oxford University Press, Oxford

Iversen S.D. , Howells R.B. , Hughes R.P. 1980 Behavioural consequences of long-term treatment with neuroleptic drugs. Advances in Biochemical Psychopharmacology 24: 305-313

Janssen P A J 1976 Structure-activity relations (SAR) and drug design as illustrated with neuroleptic agents In Antipsychotic agents pharmacodynamics and pharmacokinetics (eds G Sedrall, B Uvnas, Y Zotterman), pp 5-31 Pergamon, New York

Janssen P A J , Niemegeers C J E , Schellekens K H L 1965 Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Arneimittelforschung 15: 104-117

Jenner P. , Marsden C.D. 1979 The substituted benzamides— a novel class of dopamine antagonists. Life Sciences 25: 479-486

Johnstone E.C. , Crow T.J. , Frith C.D. , Husband J. , Kreel L. 1976 Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2: 924-926

Kalivas P.W. , Nemeroff C.B. , Prange A.J. 1984 Neurotensm microinjection into the nucleus accumbens antagonises dopamine-induced increase in locomotion and rearing. Neuroscience 4: 919-930

Kelly P.A. , Miller R.J. 1975 The interaction of neuroleptics and muscarinic agents with central dopaminergic systems. British Journal of Pharmacology 54. 115-121

Kelly P.H. , Seviour P.W. , Iversen S.D. 1975 Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research 94: 507-522

Kety S.S. 1980 The syndrome of schizophrenia, unresolved questions and opportunities for research British Journal of Psychiatry 136: 421-436

Korsgaard S. , Gerlach J. , Christensson E. 1985 Behavioural aspects of serotonin-dopamine interactions in the monkey. European Journal of Pharmacology 118: 245-252

Kovacic B. , Ruffing D. , Stanley M. 1986 Effect of neuroleptics and of potential new anti-psychotic agents (MJ 13859-1 and MJ 13980-1) on a monkey model of tardive dyskinesia . Journal of Neural Transmission 65. 39-49

Kraepelin W. 1913 Dementia praecox and paraphrenia, translated by R M Barclay from 8th German edition of the Textbook of psychiatry, vol III, part 2. E and S Livingstone, Edinburgh

Kreiskott H. 1980 In. Psychotropic agents (eds F Hoffmeister, G Stille), pp. 58-88, Springer-Verlag, New York

Kuczenski R. 1983 Biochemical actions of amphetamine and other stimulants . In: Stimulants: neurochemical behavioural and clinical perspectives (ed I. Creese), pp. 31-61. Raven Press, New York

Laborit H. , Huguervard P. , Alluarme R. 1952 Un nouveau stabilisateur vegetatif, Pe 4560 RP Presse Médicale 6: 206-208

Laduron P. , De Bie K. , Leyson J. 1979 Specific effect of haloperidol on dopamine turnover in frontal cortex. Naunyn-Schmeidebergs Archives of Pharmacology 296: 183-185

Lehmann J. , Langer S.A. 1983 The striatal cholinergic mterneuron: synaptic target of dopaminergic terminals? Neuroscience 10: 1105-1120

Levin S. 1984a Frontal lobe dysfunctions in schizophrenia— I. Eye movement impairments. Journal of Psychiatric Research 18: 27-55

Levin S. 1984b Frontal lobe dysfunctions in schizophrenia— II Impairments of psychological and brain functions Journal of Psychiatric Research 18: 57-72

Liskowsky D.R. , Potter L.T. 1987 Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol Neuropharmacology 26: 481-483

Lyon M. , Nielsen E.B. 1979 Psychosis and drug-induced stereotypies In: Psychopathology in animals research and clinical implications. (ed J D Keehn), pp 103-142. Academic Press, New York

Lyon M. , Randrup A. 1972 The dose response effect of amphetamine upon avoidance behaviour in the rat, seen as a function of increasing stereotypy Psychopharmacologia 23: 334-347

Lyon M. , Robbms T.W. 1975 The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects In: Current developments in psychopharmacology, vol 2 (eds W Essman, J Valzelli), pp. 80-163. Spectrum Press, New York

Lyon N. , Gerlach J. 1988 Perseverative structuring of responses by schizophrenic and affective disorder patients. Journal of Psychiatric Research (in press)

Lyon N. , Mejsholm B. , Lyon M. 1986 Stereotyped responding by schizophrenic outpatients: cross-cultural confirmation of perseverative switching on a two-choice task. Journal of Psychiatric Research 20: 137-150

MacKay A V P 1980 Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry 137: 379-386

MacKay A V P 1982 Antischizophrenic drugs. In: Drugs in psychiatric practice (ed P J Tyrer) pp. 42-81. Butterworths, Guildford

MacKay, A V P , Iversen L.L. , Rossor M. , Spokes E. , Bird E. , Arregui A. , Creese I. , Snyder S.H. 1982 Increased brain dopamme and dopamine receptors in schizophrenia . Archives of General Psychiatry 39: 991-997

McKinney W.T. , Bunney W.F. 1969 Animal models of depression. I. Review of evidence: implications for research. Archives of General Psychiatry 21: 240-248

Mailman R.B. , Schulz D.W. , Lewis M.H. , Staples L. , Rollema H. , De Haven D.L. 1984 SCH-23390: a selective D1 dopamme antagonist with potent D2 behavioural actions. European Journal of Pharmacology 101: 159-160

Marcus J. , Hans S.L. , Medmck S.A. , Schulsinger F. , Michelsen N. 1985 Neurological dysfunctioning in offspring of schizophrenics in Israel and Denmark. Archives of General Psychiatry 42: 753-761

Marsden C.D. , Mindham R H S , MacKay A V P 1987 Extrapyramidal movement disorders produced by antipsychotic drugs. In: The pharmacology and treatment of schizophrenia (eds P B Bradley, S R Hirsch), pp. 340-402. Oxford University Press, Oxford

Martin G.E. , Bendesky R.J. 1984 Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation. Journal of Pharmacology and Experimental Therapy 229: 706-711

Mereu G. , Collu M. , Ongini E. , Biggio G. , Gessa G.L. 1985 SCH-23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine European Journal of Pharmacology 111: 393-396

Milner B. 1963 Some effects of frontal lobectomy in man. In: The frontal granular cortex and behaviour, pp. 313-334. McGraw-Hill, New York

Molloy A.G. , Waddmgton J.L. 1985 Sniffing, rearing and locomotor responses to the D 1 dopamine agonist R-SD&F 38393 and to apomorphine: differential interactions with the selective D1 and D2 antagonists SCH-23390 and metaclopramide. European Journal of Pharmacology 108: 305-308

Munkvad I. , Pakkenberg H. , Randrup A. 1968 Aminergic systems in basal ganglia associated with stereotyped hyperactive behaviour and catalepsy. Brain Behaviour 1: 89-100

Nemeroff C.B. , Hernandez D.E. , Luttmger D. , Kalivas P.W. , Prange A.J. 1982 Interactions of neurotensm with brain dopamine systems . Annals of the New York Academy of Science 400: 330-344

Orzi F. , Dow-Edwards D. , Jehle J. , Kennedy C. , Sokoloff L. 1983 Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat . Journal of Cerebral Blood Flow Metabolism 3: 154-160

Pickar D. , Labarca R. , Linnoila M. , Roy A. , Hommer D. , Everett D. , Paul S.M. 1984 Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 225: 954-957

Pijnenburg A J J , Honig W M M , Van Rossum J.M. 1975 Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats Psychopharmacologia 41: 175-180

Porsolt R.D. , Jalfre M. 1981 Neuroleptic-induced acute dystonias in rhesus monkeys . Psychopharmacology 75: 16-21

Pycock C.J. 1980 Turning behaviour in animals. Neuroscience 5: 461-514

Randrup A. , Munkvad I. 1971 Behavioural toxicity of amphetammes studies in animal experiments In: The correlation of adverse effects in man, with observations in animals (ed. S B de Baker), Excerpta Medica, International Congress Series 220, 6-17, Excerpta Medica, Amsterdam

Reibaud M. , Blanc G. , Studler J.M. , Glowinski J. , Tassm J.P. 1984. Non-DA prefronto-cortical efferents modulate D 1 receptors in the nucleus accumbens. Brain Research 305: 43-50

Reynolds G.P. 1983 Increased concentrations and lateral assymetry of amygdala dopamine in schizophrenia. Nature London 305: 527-529

Ridley R.M. 1985 Psychostimulants in psychopharmacology, Vol 2, Part I. Preclimcal psychopharmacology (eds D G Grahame-Smith H, Hippins & G Winokur), pp. 152-179. Excerpta Medica, Amsterdam

Ridley R.H. , Baker H.F. 1982 Stereotypy in monkeys and humans. Psychological Medicine 12: 61-72

Ridley R.M. , Baker H.F. 1983 Is there a relationship between social isolation, cognitive flexibility, and behavioural stereotypy ? An analysis of the effects of amphetamine in the marmoset. In: Ethology: primate models of neuropsychiatric disorders (ed. K A Miczek), pp. 101-135. Alan R Liss, New York

Ridley R.M. , Baker H.F. , Scragg P.R. 1979 The time course of the behavioural effects of amphetamine and their reversal by haloperidol in a primate species. Biological Psychiatry 14: 753-765

Ridley R.M. , Baker H.F. , Owen F. , Cross A.J. , Crow T.J. 1982 Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology 78: 245-251

Robbms T.W. , Koob G.F. 1980 Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system Nature London 285: 409-412

Rupmak N. , Jenner P. , Marsden C. 1983 The effect of chronic neuroleptic administration on cerebral dopamine receptor function. Life Science 32: 2289-2311

Rupniak N. , Jenner P., Marsden C. 1986 Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88: 403-419

Rylander K. 1969 Clinical and medico-criminological aspects of addictions to central stimulating drugs. In: Abuse of central stimulants (eds. F Sjoqvist, M Tottle), pp 251-273. Raven Press, New York

Salamone J.D. 1987 The actions of neuroleptic drugs on appetitive instrumental behaviours In: Handbook of psychopharmacology, vol. 19 (eds L L Iversen, S D Iversen, S H Snyder), pp 575-608, Plenum Press, New York

Scatton B. 1977 Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration European Journal of Pharmacology 46: 363-369

Scatton B. 1980 Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. In: Long-term effect of neuroleptics (eds F Cattabeni, G Racagni, P F Spano, E Costa), pp 31-36, Raven Press, New York

Schneider K. 1959 Clinical psychopathology, translated by M W Hamilton, Grune and Stratton, New York

Schulsmger F. 1985 Schizophrenia: genetics and environment In: Psychopharmacology, recent advances and future prospects (ed S D Iversen), pp 185-195, Oxford University Press, Oxford

Scraggs P.R. , Ridley R.M. 1978 Behavioural effects of amphetamme in small primate. relative potencies of the d- and 1-isomers Psychopharmacology 59: 243-245

Seeman P. 1980 Antipsychotic drug doses and neuroleptic/ dopamine receptors Pharmacology Review 32: 229-313

Seiden L.S. , Dyskra L.A. 1977 Psychopharmacology: a biochemical and behavioural approach . Van Nostrand Rein-hold, New York

Slater E. 1959 Book review of amphetamine psychosis by P H Connell. British Medical Journal 1: 488

Sonsalla P.K. , Gibb J.W. , Hanson G.R. 1986 Nigrostriatal dopamine actions of the D2 receptors medicate methamphetamme effects on the striatonigral substance P system. Neuropharmacology 25: 1221-1230

Stevens J.R. 1978 Disturbances of ocular movements and blinking in schizophrenia . Journal of Neurosurgery and Psychiatry 41: 1024-1030

Stevens J.R. 1982 Neuropathology of schizophrenia. Archives of General Psychiatry 39: 1131-1139

Stevens J.R. , Livermore A. 1978 Kindling of the mesolimbic dopamine system: animal models of psychosis. Neurology 28: 36-46

Stinus L. , Nadaud D. , Jauregui J. , Kelley A.E. 1986 Chronic treatment with five different neuroleptics elicits behavioural supersensitivity to opiate infusion into the nucleus accumbens Biological Psychiatry 21: 34-48

Swerdlow N.R. , Braff D.L. , Geyer M.A. , Koob G.F. 1986 Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenia. Biological Psychiatry 21: 23-33

Thierry A.M. , Tassin J.P. , Blanc G. , Glowinski J. 1978 Studies of mesocortical dopamine systems. Advances in biochemistry and psychopharmacology 19: 205-216. Raven Press, New York

Tucker D.M. 1983 Assymetries of activation and arousal in psychopathology . Advances in Biological Psychiatry 13: 19-25

Ungerstedt U. 1971 Post synaptic supersensitivity after 6-hydroxytryptamme induced generation of the mgro striatal dopamine system Acta Physiologica Scandinavica Suppl. 367: 69-93

Waddington J.L. , Youssef H.A. 1985 Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication. Irish Medical Journal 78: 143-146

Waddmgton J.L. , Cross A.J. , Gamble S.J. , Bourne R.C. 1983 Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment Science 220: 530-532

Waddington J.L. , Youssef H.A. , Molloy A.G. , O'Boyle K. , Pugh M.T. 1985 Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. Journal of Clinical Psychiatry 46: 29-33

Weinberger D.R. , Berman K.F. , Zec R.F. 1986 Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. Archives in General Psychiatry 43: 114-124

White F.J. , Wang R.Y. 1983 Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science, 221: 1054-1057

Wong D.F. , Wagner H.N. , Tune L.E. et al. 1986 Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive shizophrenics Science, 234. 1558-1563

Worms P. , Brockkamp C L E , Lloyd K.G. 1983 Behavioural effects of neuroleptics In: Neuroleptics: neurochemical, behavioural and clinical perspectives (eds J T Coyle, S J Enna), pp. 93-117. Raven Press, New York

Worms P. , Gueudet C. , Biziere K. 1986 Induction of turning by direct intrastriatal injection of dopaminergic drugs in mice: pharmacological analysis of a simple screening model. Life Science 39: 2199-2208